Abstract:Background CHCHD2 was identified a novel cell migration-promoting gene, which could promote cell migration and altered cell adhesion when ectopically overexpressed in NIH3T3 fibroblasts, and it was identified as a protein necessary for OxPhos function as well. However, the clinic relevance of CHCHD2 expression in NSCLC remains unclear. Here we assumed that CHCHD2 expression would accompanies the expression of HIF-1α to response hypoxia in the occurrence of NSCLC. Methods In order to verify this hypothesis, correlations among the expression levels of CHCHD2 and HIF-1α were detected and analyzed in 209 pair cases of NSCLC. The expression and location of these molecules were assessed using Immunohistochemistry, immunohistofluorescence, qRT-PCR and western blotting. The differences and correlations of the expression of these two molecules with clinical pathological characteristics in NSCLC were statistically analyzed using Wilcoxon (W) text, Mann-Whitney U, Kruskal-Wallis H and cross-table tests. Kaplan-Meier survival analysis and Cox proportional hazards models were used to estimate the effect of the expression of CHCHD2 and HIF-1α on the patients’ survival. Results Data showed that CHCHD2 and HIF-1α expression were higher in NSCLC than in normal tissues (all P = 0.000). CHCHD2 expression was significantly related with smoking, tumor size, differentiation degree, TNM Stage, lymph metastasis (all P< 0.05). The HIF-1α expression was significantly associated with smoking, tumor category, differentiation degree, TNM Stage, Lymph metastasis (all P< 0.05). There was a marked correlation of CHCHD2 and HIF-1α expression with histological type, differentiation and lymph metastasis of NSCLC (all P< 0.05, r s > 0.3). Immunohistofluorescence showed that there were co-localization phenomenon in cytoplasm and nucleus between CHCHD2 and HIF-1α expression. NSCLC patients with higher CHCHD2 and HIF-1α expression had a significantly worse prognosis than those with lower CHCHD2 and HIF-1α expression (all P = 0.0001; log-rank test). The multivariate analysis indicated that CHCHD2 expression was an independent prognostic factor in NSCLC (hazard ratio [HR], 0.492, P = 0.001). Conclusion Our results indicate that over-expression of CHCHD2 would promote the expression of HIF-1α to adapt the hypoxia microenviroment in NSCLC and CHCHD2 could serves as a prognostic biomarker in NSCLC.

[Correlation Between Expression of HIF-2α and OCT-4 and Prognosis of NSCLC].

Expression of VEGF and Its Correlation with Prognosis of Small Cell Lung Cancer

Expression of hypoxia inducible factor-1α in non-small cell lung cancer

The correlation of expression levels of HIF-1α and HIF-2α in hepatocellular carcinoma with capsular invasion, portal vein tumor thrombi and patients' clinical outcome.

Co-expression of PD-L1 and HIF-1α Predicts Poor Prognosis in Patients with Non-small Cell Lung Cancer after Surgery.

The Expression and Prognostic Value of Hypoxia-Inducible Factor-1Α and P53 in Non-Small Cell Lung Carcinoma

Expression and clinical significance of hypoxia-inducible factor 1 in non small cell lung cancer

OX40 and OX40L Protein Expression of Tumor Infiltrating Lymphocytes in Non-Small Cell Lung Cancer and Its Role in Clinical Outcome and Relationships with Other Immune Biomarkers

Co-expression of HIF-1 and TLR3 is associated with poor prognosis in oral squamous cell carcinoma

Relationship Between CD4+CD25+ Treg and Expression of HIF-1α and Ki-67 in NSCLC Patients.

Correlation Between Expression of Forkhead Box M1 (FOXM1) and Clinicopathological Features and Prognosis in Patients with Non-Small Cell Lung Cancer (NSCLC)

Over-expression of ROR2 and Wnt5a Cooperatively Correlates with Unfavorable Prognosis in Patients with Non-Small Cell Lung Cancer.

Prognostic Significance of Oct4 and Sox2 Expression in Hypopharyngeal Squamous Cell Carcinoma

CHCHD2 is a Potential Prognostic Factor for NSCLC and is Associated with HIF-1a Expression.

[Expression and Clinical Significance of Hypoxia-Inducible Factor-1Alpha and Cyclooxygenase-2 in Laryngeal Squamous Cell Carcinoma].

Correlation of the expression of T lymphocyte subsets and NK cells to clinical stage and prognosis in patients with non-small cell lung cancer

Prognostic Significance Of Hypoxia-Inducible Factor Expression In Renal Cell Carcinoma A Prisma-Compliant Systematic Review And Meta-Analysis

Elevated of HSP90 associates with expression of EGFR levels and predicts poor prognosis in non-small cell lung cancer patients

[Expression of Hypoxia-Inducible Factor 1α is Associated with Lymph Node Metastasis in Oral Squamous Cell Carcinoma].

Expression of HIF-1α and Ki-67 in Non-Small Cell Lung Cancer and Its Relationship with Radiotherapy

Low Expression of SCN4B Predicts Poor Prognosis in Non-Small Cell Lung Cancer